• The leader in hyperspectral imaging for superficial tissue oximetry

  • A new generation of advanced portable imaging has arrived

  • Building upon our proven technology to establish a new standard of care

Welcome to HyperMed

Our pioneering technology has been shown in published clinical studies and peer-reviewed research, supporting accurate, non-invasive assessment of tissue oxygenation.

The Company Product Video

Hypermed Comp Img2
Hypermed Comp Img3
Hypermed Comp Img1
Hypermed Comp Img4

What are the Biomarkers of Tissue Health?

Levels of oxyhemoglobin, deoxyhemoglobin and oxygen saturation are key biomarkers of interest to assess tissue health. Assessing oxygenation in superficial tissue helps clinicians understand the localized vascular system’s ability to support tissue viability.

The Need

The Need

There are many medical applications requiring a need to quickly and efficiently determine surface tissue oxygenation. Ischemic tissue leads to complications such as non-healing wounds and surgical intervention.

Read more

The Solution

The Solution

HyperMed’s technology utilizes a proprietary form of hyperspectral imaging that is a novel and patented solution for superficial tissue oximetry. HyperMed has 34 issued patents and over 40 pending worldwide.

Read more

HyperMed’s new tissue oximetry device called HyperView™ is FDA 510(k) cleared.
HyperMed, HyperView, OxyVu™-1 and the company logo are trademarks of SafetySpect, Inc.